Abstract
Gene therapy is a novel and promising treatment strategy for brain diseases. Yet, its development is largely obscured by various in vivo transport hurdles, especially the special BBB structure of brain. Developing an ingenious delivery vehicle can provide a great solution. Conventional vehicles for brain gene delivery are viral and non-viral vectors. With inherent superiority of gene transfection, researches on viral vectors are mainly focused on problems of brain cell targeting and global brain delivery. Non-viral vectors are more studied for better brain cell entrance either directly delivered to brain or systemically delivered to the body. Novel vehicles are cell vehicles (genetically engineered or nanoparticle- carrying cells) and exosomes. They exhibit distinct and unique features compared to viral and non-viral vectors. This review gives a summarization of current advances in these four kinds of brain gene vehicles. The merits and demerits of them are also pointed out respectively. We are hoping to give a clue to the future development direction of vehicles for brain gene delivery.
Keywords: Brain gene delivery, cell vehicles, exosomes, non-viral vectors, vehicles, viral vectors, glioma, Alzheimer’s disease
Current Gene Therapy
Title:Current Advances in Vehicles for Brain Gene Delivery
Volume: 12 Issue: 5
Author(s): Xiang Zhang, Lili Zhao, Jinhui Wu, Hong Dong, Feng Xu, Guangming Gong and Yiqiao Hu
Affiliation:
Keywords: Brain gene delivery, cell vehicles, exosomes, non-viral vectors, vehicles, viral vectors, glioma, Alzheimer’s disease
Abstract: Gene therapy is a novel and promising treatment strategy for brain diseases. Yet, its development is largely obscured by various in vivo transport hurdles, especially the special BBB structure of brain. Developing an ingenious delivery vehicle can provide a great solution. Conventional vehicles for brain gene delivery are viral and non-viral vectors. With inherent superiority of gene transfection, researches on viral vectors are mainly focused on problems of brain cell targeting and global brain delivery. Non-viral vectors are more studied for better brain cell entrance either directly delivered to brain or systemically delivered to the body. Novel vehicles are cell vehicles (genetically engineered or nanoparticle- carrying cells) and exosomes. They exhibit distinct and unique features compared to viral and non-viral vectors. This review gives a summarization of current advances in these four kinds of brain gene vehicles. The merits and demerits of them are also pointed out respectively. We are hoping to give a clue to the future development direction of vehicles for brain gene delivery.
Export Options
About this article
Cite this article as:
Zhang Xiang, Zhao Lili, Wu Jinhui, Dong Hong, Xu Feng, Gong Guangming and Hu Yiqiao, Current Advances in Vehicles for Brain Gene Delivery, Current Gene Therapy 2012; 12 (5) . https://dx.doi.org/10.2174/156652312802762590
DOI https://dx.doi.org/10.2174/156652312802762590 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Unique Insights into the Actions of CNS Agents: Lessons from Studies of Chlorpyrifos and Other Common Pesticides
Central Nervous System Agents in Medicinal Chemistry The Role of Amino Acids in the Modulation of Cardiac Metabolism During Ischemia and Heart Failure
Current Pharmaceutical Design Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
Current Pharmaceutical Design Oral and Dental Considerations in the Management of Leukemic Children
Applied Clinical Research, Clinical Trials and Regulatory Affairs Luminescent Silica Nanoparticles for Cancer Diagnosis
Current Medicinal Chemistry Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders
Current Medicinal Chemistry Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use
Current Pharmaceutical Design Valproic Acid Metabolism and its Consequences on Sexual Functions
Current Drug Metabolism Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1
Current Pharmaceutical Design Glucocorticoids Pharmacology: Past, Present and Future
Current Pharmaceutical Design Targeting TNF-Alpha in HIV-1 Infection
Current Drug Targets Dendrimers As Vectors for Genetic Material Delivery to the Nervous System
Current Medicinal Chemistry Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Current Cancer Drug Targets mTOR Inhibitors in Tuberous Sclerosis Complex
Current Neuropharmacology Melatonin and Male Reproductive Health: Relevance of Darkness and Antioxidant Properties
Current Molecular Medicine Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology
Current Pharmaceutical Design Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress
Current Drug Metabolism Prediction of Mutations in H3N2 Hemagglutinins of Influenza A Virus from North America Based on Different Datasets
Protein & Peptide Letters Review of Clinical Equipoise: Examples from Oncology Trials
Current Reviews in Clinical and Experimental Pharmacology Controversies About the Chromosomal Stability of Cultivated Mesenchymal Stem Cells: Their Clinical Use is it Safe?
Current Stem Cell Research & Therapy